News on Medial

InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight

VCCircle · 10m

Malladi Drugs, a contract manufacturer of bulk drugs, is looking to boost its growth with a potential IPO in the next financial year. Backed by InvAscent, the company plans to explore the option of going public to accelerate its business expansion. Malladi Drugs reported a decline in its revenue for the past financial year and hopes that an IPO will help drive its growth efforts.